MoneyWorks4Me

Lupin submits press release

27 Jan 2020 Evaluate

Lupin has informed about submission of a Press Release as regards successful completion of the inspection carried out by the UK Medicines and Healthcare products Regulatory Agency, the regulatory agency of the United Kingdom (UK) at the Company's three manufacturing units in Pithampur (India). This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company's filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..